William S. Reardon, Director at H&Q LIFE SCIENCES INVESTORS (HQL), bought 772 shares at $13.27 ($10K) on 2012-03-09, disclosed to the SEC on 2012-03-12.
Open-market purchase of $10k HQL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HQL | BUY | 2014-07-01 | $4K | — | Filing → |
| SNTA | BUY | 2013-11-15 | $50K | — | Filing → |
| IDRA | BUY | 2013-09-17 | $25K | — | Filing → |